CN1432388A - Sheep fetus peptide oral liquid and its prepn - Google Patents
Sheep fetus peptide oral liquid and its prepn Download PDFInfo
- Publication number
- CN1432388A CN1432388A CN 02160341 CN02160341A CN1432388A CN 1432388 A CN1432388 A CN 1432388A CN 02160341 CN02160341 CN 02160341 CN 02160341 A CN02160341 A CN 02160341A CN 1432388 A CN1432388 A CN 1432388A
- Authority
- CN
- China
- Prior art keywords
- caprae seu
- seu ovis
- oral liquid
- foetus caprae
- herbal medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The sheep fetus peptide oral liquid is prepared with sheep fetus and/or placenta as main material, Chinese medicinal materials wolfberry fruit, longan, sea-buck thorn, etc., seasoning and water. The preparation process includes the steps of pre-treatment of sheep fetus and/or placenta, homogenization, superfine crushing, protein hydrolysis, ultrafiltering to extract, addition of extracted active Chinese medicine components, packing, sterilizing, etc. The oral liquid contains rich short periods, amino acids, polysaccharide, flavones, vitamines and trace elements. It has obvious immunity regulating and senility delaying functions, is easy to absorb and utilize and has stable effect.
Description
Technical field the present invention relates to a kind of health product, particularly extracts small peptide from healthy Foetus Caprae seu Ovis and Placenta Hominis, and with the adjusting immunity of rare Chinese medicine compatibilities such as Fructus Lycii, Arillus Longan, Fructus Hippophae, the health product of slow down aging.
Background technology is along with the sustainable growth of China's economy, and people's living standard improves constantly, and be not satisfied with basic material requisite, then pursues higher level material and spiritual enjoyment.Healthy, as to have maintained vigour and pursued fresh target into people, but China has the population more than 1/3 to be in sub-health state because of reasons such as aspect such as diet and work, and nouns such as computer disease, affluenza emerge in an endless stream.This just makes the adjusting organism balance, improves health, and prevents and cures diseases, and slow down aging has been mentioned important position.Accomplish this point, just must regulate, reach the purpose that promotes immunologic function, slow down aging the metabolic processes of human body.
Various Placenta caprae seu ovis class health product are also arranged on the market, but this prescription is based on prairie, Inner Mongol rich in natural resources, prescription is reasonable, clear efficacy, production technology advanced person.
The Chinese invention patent communique discloses a kind of " tonic oral liquid of sheep placenta extract ", publication number CN1279109A January 10 calendar year 2001.Prescription is Placenta caprae seu ovis hydrolyzed solution, fructus lycii extracted solution, tea polyphenols, vitamin E, silk peptide etc.Its deficiency is not have the promotion of attention to spleen and stomach function when noting nutritional labeling, to help the absorption of digestive system to oral liquid.And this oral liquid has also been noticed the maintenance to taste when guaranteeing polysaccharide, total flavones, aminoacid and other compositions, is more conducive to the absorption to various compositions.To reach the adjusting organism balance, improve health, prevent and cure diseases the slow down aging purpose.
Summary of the invention the objective of the invention is: change in the past to the processing mode of Foetus Caprae seu Ovis and/or Placenta Hominis, adopt special extracting method, wherein active component etc. is extracted to greatest extent.Add the effective ingredient that from Fructus Lycii, Arillus Longan, Fructus Hippophae, extracts simultaneously, make the health care oral liquid of health-care effects such as having immunomodulating and slow down aging.
Foetus Caprae seu Ovis peptide oral liquid of the present invention is achieved in that with Foetus Caprae seu Ovis and/or Placenta Hominis be primary raw material, be equipped with Chinese herbal medicine such as Fructus Lycii, Arillus Longan, Fructus Hippophae, its percentage by weight is: Foetus Caprae seu Ovis and/or placenta extracting liquid 15～20%, extracts of Chinese herbal medicine 10～15%, flavoring agent 3--5%, surplus is a water.
The ratio of Fructus Lycii, Fructus Hippophae, three kinds of extracting solution of Arillus Longan is: 2: 2: 1.
The preparation method of Foetus Caprae seu Ovis peptide oral liquid: full Foetus Caprae seu Ovis and/or Placenta Hominis homogenate after pretreatment, through micronized pulverization, Proteolytic enzyme, ultrafiltration is extracted, and adds the Chinese herbal medicine active component that extracts, fill, the biological product based on Foetus Caprae seu Ovis peptide that prepared such as sterilization go out.The step of making in the Foetus Caprae seu Ovis peptide oral liquid process is as follows:
One, Proteolytic enzyme: with pretreated full Foetus Caprae seu Ovis and/or Placenta Hominis homogenate, homogenate reuse colloid mill carries out micronized pulverization.Under 45～50 ℃ of conditions, add trypsin, enzymolysis 6～8 hours.
Two, centrifugal ultrafiltration: enzymolysis solution centrifugal (4000～6000 rev/mins) is gone precipitation, and supernatant carries out ultrafiltration (molecular cut off is below 10000), collects ultrafiltrate.
Three, Chinese herbal medicine extracting: Fructus Lycii, Fructus Hippophae, Arillus Longan etc. are extracted preparation in proportion.
1, Fructus Lycii is extracted: Fructus Lycii is steeped through water logging, and broken homogenate, is removed slag at heated and boiled, gets supernatant.
2, Fructus Hippophae is extracted: Fructus Hippophae adds 95% ethanol, 85 ℃ of reflux, extract,, and centrifugal removing slag, extracting solution concentrates.
3, Arillus Longan is extracted; Arillus Longan was soaked two hours, broken homogenate, and heated and boiled, separation is removed slag, and gets supernatant.
Four, allotment: the Foetus Caprae seu Ovis and the placenta extracting liquid that extract are put into blend tank, add the extracts of Chinese herbal medicine that extracts by proportioning, add sucrose, citric acid again.
Five, fill, sterilization, packing: deployed oral liquid is carried out fill, sterilization, packing.
Advantage of the present invention is: compare with other oral liquid health product of regulating immunity, slow down aging, the present invention is a primary raw material with Foetus Caprae seu Ovis and Placenta Hominis, be equipped with Fructus Lycii, Fructus Hippophae, Arillus Longan, form through production technologies such as Proteolytic enzyme, centrifugal ultrafiltration, allotment, fill, sterilization, packing are refining.This product is rich in multiple small peptide and aminoacid, polysaccharide, flavonoid, vitamin and trace element, the eight seed amino acid reasonable mixture ratio that human body is necessary.This oral liquid is low at immunocompetence, the mid-aged population of weak senilism, has tangible effect of regulating immunity, slow down aging.Be beneficial to absorption of human body, utilization, stable effect.After taking one month continuously, immunocompetence improves, and the disease resistance ability is enhanced, and senile symptom is alleviated.In fatigue alleviating and adjusting metabolism certain effect is arranged also.
The specific embodiment one, Proteolytic enzyme: get Placenta caprae seu ovis in three months by animal quarantine and Foetus Caprae seu Ovis after pretreatment, add the same amount distilled water, homogenate under 12000～15000 rev/mins of conditions.Homogenate is carried out micronized pulverization with colloid mill, under 45～50 ℃ of conditions, added trypsin 1: 250 then) enzymolysis 6～8 hours.
Two, centrifugal ultrafiltration: enzymolysis solution under 4000-6000 rev/min of condition, centrifugal 25-30 minute, is got supernatant.Supernatant carries out ultrafiltration, and molecular cut off is below 10000, collects ultrafiltrate.
Three, Chinese herbal medicine extracting:
1, Fructus Lycii is extracted: Fructus Lycii adds 3 times of water logging bubbles two hours after pretreatment, broken homogenate, and heated and boiled 30 minutes, centrifugalize is removed slag, and gets supernatant.
2, Fructus Hippophae is extracted: Fructus Hippophae adds 5 times of 95% ethanol, 85 ℃ of reflux, extract, 30 minutes, and centrifugal removing slag, extracting solution concentrates.
3, Arillus Longan is extracted; Arillus Longan adds 5 times of water logging bubbles two hours after pretreatment, broken homogenate, and heated and boiled 30 minutes, centrifugalize is removed slag, and gets supernatant.
The ratio of Fructus Lycii, Fructus Hippophae, three kinds of extracting solution of Arillus Longan is: 2: 2: 1.
Four, allotment: the Foetus Caprae seu Ovis and the placenta extracting liquid that extract are put into blend tank, add the extracts of Chinese herbal medicine that extracts by proportioning, add 5% sucrose, citric acid again and cook flavoring agent.
Five, fill, sterilization, check is packaged into box and is finished product.
Six, instructions of taking: sooner or later respectively once, each one.
Claims (3)
1, a kind of Foetus Caprae seu Ovis peptide oral liquid, it is characterized in that with full Foetus Caprae seu Ovis and/or Placenta Hominis be primary raw material, be equipped with Chinese herbal medicine such as Fructus Lycii, Arillus Longan, Fructus Hippophae, its percentage by weight is respectively: Foetus Caprae seu Ovis and/or placenta extracting liquid 15～20%, extracts of Chinese herbal medicine 10～15%, flavoring agent 3～5%, surplus are water.
2, a kind of Foetus Caprae seu Ovis peptide oral liquid according to claim 1 is characterized in that the extracts of Chinese herbal medicine in the component is Fructus Lycii, Fructus Hippophae, Arillus Longan, and its proportioning is 2: 2: 1.
3, according to the preparation method of the described a kind of Foetus Caprae seu Ovis peptide oral liquid of claim 1, it is characterized in that: the homogenate after pretreatment of Foetus Caprae seu Ovis and/or Placenta Hominis, through micronized pulverization, Proteolytic enzyme, ultrafiltration is extracted, and adds the Chinese herbal medicine active component that extracts, fill, the biological product that prepared such as sterilization go out based on Foetus Caprae seu Ovis peptide, the step of making in the Foetus Caprae seu Ovis peptide oral liquid process is as follows:
(1) Proteolytic enzyme: with pretreated full Foetus Caprae seu Ovis and/or Placenta Hominis homogenate, homogenate reuse colloid mill carries out micronized pulverization.Under 45～50 ℃ of conditions, add trypsin, enzymolysis 6～8 hours;
(2) centrifugal ultrafiltration: enzymolysis solution centrifugal (4000～6000 rev/mins) is gone precipitation, and supernatant carries out ultrafiltration (molecular cut off is below 10000), collects ultrafiltrate;
(3) Chinese herbal medicine extracting: Fructus Lycii, Fructus Hippophae, Arillus Longan etc. are extracted preparation in proportion.
Fructus Lycii is extracted: Fructus Lycii is steeped through water logging, and broken homogenate, is removed slag at heated and boiled, gets supernatant;
Fructus Hippophae is extracted: Fructus Hippophae adds 95% ethanol, 85 ℃ of reflux, extract,, and centrifugal removing slag, extracting solution concentrates;
Arillus Longan is extracted: Arillus Longan was soaked two hours, broken homogenate, and heated and boiled, separation is removed slag, and gets supernatant;
(4) allotment: the Foetus Caprae seu Ovis and the placenta extracting liquid that extract are put into blend tank, add the extracts of Chinese herbal medicine that extracts by proportioning, add sucrose, citric acid again;
(5) fill, sterilization, packing: deployed oral liquid is carried out fill, sterilization, packing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02160341 CN1432388A (en) | 2002-12-26 | 2002-12-26 | Sheep fetus peptide oral liquid and its prepn |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02160341 CN1432388A (en) | 2002-12-26 | 2002-12-26 | Sheep fetus peptide oral liquid and its prepn |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1432388A true CN1432388A (en) | 2003-07-30 |
Family
ID=27628819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02160341 Pending CN1432388A (en) | 2002-12-26 | 2002-12-26 | Sheep fetus peptide oral liquid and its prepn |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1432388A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102318816A (en) * | 2011-05-19 | 2012-01-18 | 大连九羊食品有限公司 | Sheep placenta extraction process |
| CN110317847A (en) * | 2019-05-24 | 2019-10-11 | 科索瑞生物科技(天津)有限公司 | A kind of extract and its preparation method and application in animal tissue source |
| CN110559321A (en) * | 2019-09-11 | 2019-12-13 | 豢龙实业集团有限公司 | Lingti oral liquid and preparation method thereof |
| CN113616771A (en) * | 2020-05-09 | 2021-11-09 | 吉林省拓华生物科技有限公司 | Lyophilized powder of active protein extracted from placenta Cervi, placenta Cervi oral liquid and their preparation methods |
| CN114766619A (en) * | 2022-05-30 | 2022-07-22 | 中山市美太保健制品有限公司 | Health-care product oral liquid for delaying senility and preparation method thereof |
| WO2023001246A1 (en) * | 2021-07-23 | 2023-01-26 | 史宗洁 | Method for preparing polypeptide-containing fetal sheep zymolyte and use thereof |
-
2002
- 2002-12-26 CN CN 02160341 patent/CN1432388A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102318816A (en) * | 2011-05-19 | 2012-01-18 | 大连九羊食品有限公司 | Sheep placenta extraction process |
| CN102318816B (en) * | 2011-05-19 | 2015-09-02 | 大连九羊食品有限公司 | A kind of extraction process of sheep placenta |
| CN110317847A (en) * | 2019-05-24 | 2019-10-11 | 科索瑞生物科技(天津)有限公司 | A kind of extract and its preparation method and application in animal tissue source |
| CN110317847B (en) * | 2019-05-24 | 2021-11-26 | 科索瑞生物科技(天津)有限公司 | Extract from animal tissue, and preparation method and application thereof |
| CN110559321A (en) * | 2019-09-11 | 2019-12-13 | 豢龙实业集团有限公司 | Lingti oral liquid and preparation method thereof |
| CN113616771A (en) * | 2020-05-09 | 2021-11-09 | 吉林省拓华生物科技有限公司 | Lyophilized powder of active protein extracted from placenta Cervi, placenta Cervi oral liquid and their preparation methods |
| WO2023001246A1 (en) * | 2021-07-23 | 2023-01-26 | 史宗洁 | Method for preparing polypeptide-containing fetal sheep zymolyte and use thereof |
| CN114766619A (en) * | 2022-05-30 | 2022-07-22 | 中山市美太保健制品有限公司 | Health-care product oral liquid for delaying senility and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101642176B (en) | Method for preparing wild jujube honey tea for relieving neurasthenia | |
| CN100443001C (en) | Health tea drink of Aizoon stonecrop herb | |
| CN103484281A (en) | Method of manufacturing maca wine | |
| CN103919227B (en) | A kind of maize oligopeptide beverage with memory reinforcing effect and production technology thereof | |
| CN101380128B (en) | Zhukui multifunctional health care beverage and production method thereof | |
| CN104872775B (en) | A kind of compound fat-reducing solid beverage of green tea tea polysaccharide and application | |
| CN1432388A (en) | Sheep fetus peptide oral liquid and its prepn | |
| CN1709384A (en) | Ovarium-nourishing capsule for regulating female incretion and its preparing method | |
| CN111820348A (en) | Saussurea involucrata culture ossein peptide composite fruit juice and preparation method thereof | |
| CN107156820A (en) | Conditioning women postpartum is damaged nutraceutical of constitution and preparation method thereof comprehensively | |
| CN106722258A (en) | A kind of astaxanthin colla corii asini cake and preparation method thereof | |
| CN106261244A (en) | A kind of mandarin orange Herba Passiflorae Caeruleae mulse and preparation method thereof | |
| CN1069817C (en) | Sea-buckthorn tea and its preparation | |
| CN106135969A (en) | A kind of Cerasus humilis Bunge Herba Passiflorae Caeruleae mulse and preparation method thereof | |
| CN101690533B (en) | Manufacturing method of red data tea beverage | |
| CN101756181A (en) | Healthy beverage with integrated taste | |
| CN105087284B (en) | A kind of compound raspberry health preserving wine and preparation method thereof | |
| CN109805235B (en) | Wheat-flavor composite polypeptide solid beverage for assisting in reducing hypertension, hyperglycemia and hyperlipidemia, and preparation method and application thereof | |
| CN1425443A (en) | Brain invigorating oral administration liquid and its preparing method | |
| CN1291000C (en) | Natural wild fruit health care wine and its production method | |
| CN106261328A (en) | A kind of Fructus Citri grandis Herba Passiflorae Caeruleae mulse and preparation method thereof | |
| CN104824758A (en) | Compound anti-aging traditional Chinese medicine health-care drink and preparation method therefor | |
| CN116172083A (en) | Total nutrient formula food for improving spleen and stomach functions and preparation method thereof | |
| CN1559570A (en) | Natural nutritive liquid and its preparation method | |
| CN1091008A (en) | Pearl oral liquid and production technology thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |